About UsNewsShop
Fighting hereditary breast and ovarian cancer
Information & Research
| More

Ovarian Cancer Survivors

  • Basics

BRCA1 Functions as a Differential Modulator of Chemotherapy-induced Apoptosis
Jennifer E. Quinn, Richard D. Kennedy, Paul B. Mullan, Paula M. Gilmore, Michael Carty, Patrick G. Johnston and D. Paul Harkin. Cancer Research. Volume 63: p. 6221-6228, October 2003.

Improved survival in women with BRCA-associated ovarian carcinoma
Ilana Cass, M.D., Rae Lynn Baldwin, Ph.D., Taz Varkey, M.D., Roxana Moslehi, Ph.D., Steven A. Narod, M.D., Beth Y. Karlan, M.D. Cancer. Volume 97, Issue 9: p. 2187-2195, April 2003.

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors
Y. Ben David, A. Chetrit, G. Hirsh-Yechezkel, E. Friedman, B.D. Beck, U. Beller, G. Ben-Baruch, A. Fishman, H. Levavi, F. Lubin, J. Menczer, B. Piura, J.P. Struewing, B. Modan. Journal of Clinical Oncology. Volume 20, Issue 2: p. 463-466, January, 2002.

BRCA germline mutations in Jewish women with uterine serous papillary carcinoma
Ofer Lavie, Gila Hornreich, Alon Ben-Arie, Gad Rennert, Yoram Cohen, Rehuven Keidar, Shlomi Sagi, Efrat Levy Lahad, Ron Auslander and Uzi Beller. Gynecologic Oncology, Volume 92, Number 2: p. 521-524, February 2004.


Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.

Privacy Policy | Sitemap | Contact Us

Morphtek

This site has been made possible by a generous grant from Morphotek.


Web design by Rareheron Web Design

copyright © FORCE: Facing Our Risk of Cancer Empowered, Inc.  •  info@facingourrisk.org